Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have published a landmark review on BH3 mimetics—a new class of drugs that are reshaping the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback